Back to search results

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Warts

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Utah Midvalley Health Center, Salt Lake City, Utah, United States

    Contact: Study coordinator (Lowell Nicholson, MD) · lowell.nicholson@hsc.utah.edu · 801-581-2121
    Contact: Principal Investigator (Lowell Nicholson, MD)
    Jamie Rhoads, MD (Sub-investigator)
    Stephanie Klein, MD (Sub-investigator)

  • VA Salt Lake City Health Care System, Salt Lake City, Utah, United States

    Contact: Study coordinator (Jamie Rhoads, MD) · jamie.rhoads@hsc.utah.edu · 801-582-1565
    Contact: Principal Investigator (Jamie Rhoads, MD)
    Lowell Nicholson, MD (Sub-investigator)
    Stephanie Klein, MD (Sub-investigator)
Study leads

  • Lowell Nicholson, MD

    Principal Investigator

    University of Utah Health Care System

View source on ClinicalTrials.gov(opens in a new tab)